Search
for
Sort by
Research 601–630 of 1000+
- A Systematic Review and Meta-analysis of Randomized Controlled Trials of United States Food and Drug Administration-Approved, Home-use, Low-Level Light/Laser Therapy Devices for Pattern Hair Loss: Device Design and Technology.
- Elevation of transaminases after MMP® session with methotrexate for alopecia areata treatment – how much do we know about the risks of systemic absorption of the technique?
- Effect of Fibroblast Growth Factor 10 and an Interacting Non-Coding RNA on Secondary Hair Follicle Dermal Papilla Cells in Cashmere Goats’ Follicle Development Assessed by Whole-Transcriptome Sequencing Technology
- Commentaries on Micro/Minigrafting vs Follicular Unit Transplantation: An Assessment of the Recent Bernstein/Rassman Article, “Follicular Unit Graft Yield Using Three Different Techniques”
- Hair Transplant: Classification, Analysis, and Treatment Planning of Male Pattern Hair Loss and Newer Techniques in FUT Hair Restoration
- Hyaluronic acid: elucidating its penetration into, and effect on hair fibers using confocal Raman spectroscopy and biometric techniques
- scMC learns biological variation through the alignment of multiple single-cell genomics datasets
- Patient factors influencing dermal filler complications: prevention, assessment, and treatment
- Microenvironmental reprogramming of thymic epithelial cells to skin multipotent stem cells
- Adverse cutaneous reactions to soft tissue fillers – a review of the histological features
- FOXN1: A Master Regulator Gene of Thymic Epithelial Development Program
- The structural and functional aspects of hair cell regeneration in the chick as a result of exposure to intense sound
- Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis
- Morphogenesis and maintenance of the 3D thymic medulla and prevention of nude skin phenotype require FoxN1 in pre- and post-natal K14 epithelium
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Biological significance of FoxN1 gain-of-function mutations during T and B lymphopoiesis in juvenile mice
- Titrated extract of<i>Centella asiatica</i>increases hair inductive property through inhibition of STAT signaling pathway in three-dimensional spheroid cultured human dermal papilla cells
- Subcellular localization of the five members of the human steroid 5α-reductase family
- Expression Profiles of Tyrosine Kinases in Cultured Follicular Papilla Cells Versus Dermal Fibroblasts
- P63 targeted deletion under the FOXN1 promoter disrupts pre-and post-natal thymus development, function and maintenance as well as induces severe hair loss
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- FDA approves Pfizer's JAK inhibitor for adolescents with alopecia areata hair loss
- Accessibility of direct-to-consumer teledermatology to underserved populations
- Imaging prostate cancer (PCa) with [<sup>99m</sup> Tc(CO)<sub>3</sub> ]finasteride dithiocarbamate
- Real-world assessment of ritlecitinib in patients with severe alopecia areata: a 24-week multicentre retrospective study
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Clinical and Trichoscopic Correlation of Scalp in Patients Who had undergone Hair Transplantation
- The Business of Hair Restoration: Can New Doctors Penetrate It?
- Pediatric Clinical Trial Program in Progress: A Phase 3 Study and Long-term Extension Study to Evaluate the Efficacy and Safety of Ritlecitinib in Children 6 to <12 years of Age With Severe Alopecia Areata